BBR Partners’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $239K | Hold |
20,988
| – | – | 0.01% | 209 |
|
2025
Q1 | $249K | Hold |
20,988
| – | – | 0.02% | 193 |
|
2024
Q4 | $395K | Hold |
20,988
| – | – | 0.03% | 165 |
|
2024
Q3 | $472K | Hold |
20,988
| – | – | 0.04% | 141 |
|
2024
Q2 | $438K | Hold |
20,988
| – | – | 0.04% | 122 |
|
2024
Q1 | $309K | Hold |
20,988
| – | – | 0.02% | 190 |
|
2023
Q4 | $217K | Hold |
20,988
| – | – | 0.02% | 167 |
|
2023
Q3 | $165K | Buy |
+20,988
| New | +$165K | 0.02% | 183 |
|
2023
Q2 | – | Sell |
-20,988
| Closed | -$186K | – | 163 |
|
2023
Q1 | $186K | Buy |
+20,988
| New | +$186K | 0.02% | 155 |
|